ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS
A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sa...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ALBRECHT, Balazs TRAAS, Anne Michelle LEHNER, Stefan Johannes STARK, Marcus ANKE, Sven ZIMMERING, Tanja Margrit KLEY, Saskia |
| description | A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019008831A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019008831A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019008831A13</originalsourceid><addsrcrecordid>eNqNjDEKwkAQRdNYiHqHAWshMU0sh3WSTJHZsDMGrJYgayUaiPfHCB7A6vEen7_OIkrD3kiUBZghkKPefAAUw8YLq0G9qLUEfaCBxNgLfEsgtG5x8DXoVY06dnBmJVRSWO4cmm6z1X18zGn34ybb12SuPaTpFdM8jbf0TO940WNenPK8qsoCi_K_1Qc8yDRH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS</title><source>esp@cenet</source><creator>ALBRECHT, Balazs ; TRAAS, Anne Michelle ; LEHNER, Stefan Johannes ; STARK, Marcus ; ANKE, Sven ; ZIMMERING, Tanja Margrit ; KLEY, Saskia</creator><creatorcontrib>ALBRECHT, Balazs ; TRAAS, Anne Michelle ; LEHNER, Stefan Johannes ; STARK, Marcus ; ANKE, Sven ; ZIMMERING, Tanja Margrit ; KLEY, Saskia</creatorcontrib><description>A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190110&DB=EPODOC&CC=US&NR=2019008831A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25566,76549</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190110&DB=EPODOC&CC=US&NR=2019008831A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ALBRECHT, Balazs</creatorcontrib><creatorcontrib>TRAAS, Anne Michelle</creatorcontrib><creatorcontrib>LEHNER, Stefan Johannes</creatorcontrib><creatorcontrib>STARK, Marcus</creatorcontrib><creatorcontrib>ANKE, Sven</creatorcontrib><creatorcontrib>ZIMMERING, Tanja Margrit</creatorcontrib><creatorcontrib>KLEY, Saskia</creatorcontrib><title>ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS</title><description>A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjDEKwkAQRdNYiHqHAWshMU0sh3WSTJHZsDMGrJYgayUaiPfHCB7A6vEen7_OIkrD3kiUBZghkKPefAAUw8YLq0G9qLUEfaCBxNgLfEsgtG5x8DXoVY06dnBmJVRSWO4cmm6z1X18zGn34ybb12SuPaTpFdM8jbf0TO940WNenPK8qsoCi_K_1Qc8yDRH</recordid><startdate>20190110</startdate><enddate>20190110</enddate><creator>ALBRECHT, Balazs</creator><creator>TRAAS, Anne Michelle</creator><creator>LEHNER, Stefan Johannes</creator><creator>STARK, Marcus</creator><creator>ANKE, Sven</creator><creator>ZIMMERING, Tanja Margrit</creator><creator>KLEY, Saskia</creator><scope>EVB</scope></search><sort><creationdate>20190110</creationdate><title>ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS</title><author>ALBRECHT, Balazs ; TRAAS, Anne Michelle ; LEHNER, Stefan Johannes ; STARK, Marcus ; ANKE, Sven ; ZIMMERING, Tanja Margrit ; KLEY, Saskia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019008831A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ALBRECHT, Balazs</creatorcontrib><creatorcontrib>TRAAS, Anne Michelle</creatorcontrib><creatorcontrib>LEHNER, Stefan Johannes</creatorcontrib><creatorcontrib>STARK, Marcus</creatorcontrib><creatorcontrib>ANKE, Sven</creatorcontrib><creatorcontrib>ZIMMERING, Tanja Margrit</creatorcontrib><creatorcontrib>KLEY, Saskia</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ALBRECHT, Balazs</au><au>TRAAS, Anne Michelle</au><au>LEHNER, Stefan Johannes</au><au>STARK, Marcus</au><au>ANKE, Sven</au><au>ZIMMERING, Tanja Margrit</au><au>KLEY, Saskia</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS</title><date>2019-01-10</date><risdate>2019</risdate><abstract>A method is described for the prophylaxis or treatment of hypertension in a cat in need of such treatment. The method includes administration of a therapeutically effective amount of angiotensin II receptor 1 (AT-1) antagonist (sartan) to the cat, where the therapeutically effective amount of the sartan is administered in a daily dosage amount that is varied over a treatment period, the daily dosage amount of the sartan for a first period of time during the treatment period is 1.0 to 5.0 mg/kg of body weight, and the daily dosage amount of the sartan is decreased for a second period of time subsequent the first period of time during the treatment period.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2019008831A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | ANGIOTENSIN II RECEPTOR ANTAGONIST FOR THE PREVENTION OR TREATMENT OF SYSTEMIC DISEASES IN CATS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T07%3A39%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ALBRECHT,%20Balazs&rft.date=2019-01-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019008831A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |